Lex Aurum Advisors, LLC Imv Inc. Transaction History

Lex Aurum Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$0.47 - $0.75 $36,660 - $58,500	78,000 Added 43.85%	255,870 $134,000
Q2 2022 Aug 05, 2022	BUY	$0.56 - $1.45 $5,096 - $13,195	9,100 Added 5.39%	177,870 $116,000
Q1 2022 May 04, 2022	BUY	$1.07 - $1.5 $4,494 - $6,300	4,200 Added 2.55%	168,770 $238,000
Q4 2021 Jan 24, 2022	BUY	$1.22 - $1.78 $82,350 - $120,150	67,500 Added 69.54%	164,570 $201,000
Q3 2021 Nov 03, 2021	BUY	$1.35 - $2.16 $86,359 - $138,175	63,970 Added 193.26%	97,070 $161,000
Q2 2021 Jul 19, 2021	BUY	$2.12 - $3.24 $70,172 - $107,244	33,100 New	33,100 $72,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lex Aurum Advisors, LLC with notifications on news.